MustGrow Biologics Corp. (MGRO.V)
| Previous Close | 1.1500 |
| Open | 1.1500 |
| Bid | 1.1600 x N/A |
| Ask | 1.1800 x N/A |
| Day's Range | 1.1500 - 1.2100 |
| 52 Week Range | 0.6200 - 1.6000 |
| Volume | |
| Avg. Volume | 14,482 |
| Market Cap | 61.969M |
| Beta (5Y Monthly) | 1.66 |
| PE Ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings Date | Nov 27, 2024 - Dec 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
MustGrow Provides 2024 Pipeline Update
MustGrow transitions from R&D to commercialization.TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026.Commercialization of TerraMGTM soil biopesticide is progressing under the Bayer commercial agreement in the EU, Middle East and Africa.Registration work for TerraMGTM soil biopesticide continues in the U.S. and Canada.Expiration of exclusive non-commercial agreements.Intellectual property portfolio continues to grow. Man
NewsfileMustGrow Receiving Funding from Agriculture and Agri-Food Canada for Human and Animal Health Applications
MustGrow will be receiving funding from Agriculture and Agri-Food Canada to investigate mustard-derived ingredient opportunities in human & animal health applications.Potential product opportunities may include application in functional foods and nutraceuticals for improved immunity and gut health in humans, as natural food preservatives, as well as a replacement for antibiotics in animal feeds.Saskatoon, Saskatchewan--(Newsfile Corp. - September 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO)
NewsfileMustGrow Receives Florida Registration for TerraSante(TM) Biofertility Product
MustGrow has received approval from the Florida Department of Agriculture and Consumer Services to commence sales of TerraSanteTM, an organic biofertility product, in the State of Florida.Mustard-derived TerraSanteTM focuses on soil and soil microbiome health, nutrient/water use efficiencies, and plant yields.Saskatoon, Saskatchewan--(Newsfile Corp. - September 11, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE:0C0) (the "Company" or "MustGrow") is pleased to announce receipt
